Enjoy Interactive Tools and Indicators
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
| MELSEN GREGORY J | CEO | Dec 18 | Option Exercise | 49.43 | 1,012 | 50,023 | 1,438 | Dec 19 10:38 AM |
| OCONNELL HOWARD V | Director | Oct 26 | Option Exercise | 37.10 | 5,000 | 185,500 | 95,639 | Nov 28 11:22 AM |
| OCONNELL HOWARD V | Director | Oct 26 | Sale | 71.81 | 8,000 | 574,480 | 87,639 | Nov 28 11:22 AM |
| VERONNEAU MARCEL | VP Hematology Operations | Aug 14 | Option Exercise | 51.60 | 475 | 24,510 | 35,044 | Aug 16 04:04 PM |
| VERONNEAU MARCEL | VP Hematology Operations | Aug 14 | Sale | 67.57 | 475 | 32,096 | 34,569 | Aug 16 04:04 PM |
| MELSEN GREGORY J | VP Finance and CFO | Jul 31 | Option Exercise | 51.60 | 426 | 21,982 | 426 | Aug 01 09:54 AM |